Tazarotene Cream
Product Images NDC 0713-0765

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tazarotene (NDC 0713-0765). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cosette Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 G Carton (30g Carton)

30 G Carton (30g Carton)
Tazarotene Cream 0.1% topical formulation in a 30 g package by Cosette Pharmaceuticals, Inc. The label highlights active ingredient concentration and specifies topical use only, excluding oral, ophthalmic, or intravaginal applications. The packaging includes dosage guidelines and ingredient information along with the NDC 0713-0670-31 and barcode.*
FDA Label Image

30 G Tube (30g Tube)

30 G Tube (30g Tube)
Label for Tazarotene Cream 0.1% topical, 30 g tube. The label states it is prescription only (Rx only) and warns against oral, ophthalmic, or intravaginal use. Active ingredient is Tazarotene 0.1% w/w. Inactive ingredients and storage instructions are listed. Distributed by Cosette Pharmaceuticals, Inc.*
FDA Label Image

60 G Carton (60g Carton)

60 G Carton (60g Carton)
The image shows a flat layout of a carton for Tazarotene Cream 0.1%, a topical prescription drug. The package indicates a 60 g quantity and highlights the active ingredient as Tazarotene 0.1% (w/w). The labeler is Cosette Pharmaceuticals, Inc. Usage instructions specify topical use only, not for oral, ophthalmic, or intravaginal use. The design includes barcode data and storage instructions.*
FDA Label Image

60 G Tube (60g Tube)

60 G Tube (60g Tube)
Packaging label for Tazarotene Cream 0.1% (1 mg/g) topical cream in a 60 g tube. The label includes the NDC 0713-0670-60 and states the product is for topical use only, not for oral, ophthalmic, or intravaginal use. It lists Cosette Pharmaceuticals, Inc. as the labeler, along with storage and ingredient information, and features a barcode.*
FDA Label Image

Structural Formula (Tazstructure2)

Structural Formula (Tazstructure2)
Chemical structure of tazarotene shown as a molecular diagram, including its characteristic heterocyclic rings and functional groups, labeled with the name 'TAZAROTENE' underneath.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.